Clinical Efficacy and Safety of CD47 Monoclonal Antibody Combined With Azacitidine in the Treatment of Recurrent AML After Transplantation
Clinical trial NCT05266274 · UNKNOWN
Trial details
- NCT number
- NCT05266274
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2023-06-30
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.